XML 73 R63.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share - Calculations of (Loss) Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Earnings Per Share [Abstract]        
Net (loss) income attributable to Merck & Co., Inc., basic $ (5,975) $ 3,944 $ (3,154) $ 8,254
Net (loss) income attributable to Merck & Co., Inc., diluted $ (5,975) $ 3,944 $ (3,154) $ 8,254
Average common shares outstanding (in shares) 2,539 2,531 2,539 2,529
Common shares issuable (in shares) 0 9 0 9
Average common shares outstanding assuming dilution (in shares) 2,539 2,540 2,539 2,538
Basic (Loss) Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) $ (2.35) $ 1.56 $ (1.24) $ 3.26
(Loss) Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) $ (2.35) $ 1.55 $ (1.24) $ 3.25